 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
SUMMARIES FOR PATIENTS
Who Benefits from Implantable Heart Defibrillators?
18 March 2003 | Volume 138 Issue 6 | Page I-40
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine.
The summary below is from the full report titled "Implantable Cardioverter Defibrillators in Primary and Secondary Prevention: A Systematic Review of Randomized, Controlled Trials." It is in the 18 March 2003 issue of Annals of Internal Medicine (volume 138, pages 445-452). The authors are JA Ezekowitz, PW Armstrong, and FA McAlister.
What is the problem and what is known about it so far?
Cardiac arrest is a sudden failure of the heart to pump blood. The most common reason for cardiac arrest is an electrical problem called ventricular fibrillation. Ventricular fibrillation causes the lower chambers (ventricles) of the heart to rapidly contract in an uncoordinated manner. This prevents the heart from pumping blood. Death usually occurs within 5 minutes unless pumping of the heart is maintained by external cardiac massage or the heartbeat is returned to its normal rhythm by an electrical shock (electrical defibrillation). Risk for cardiac arrest is increased in various people, including patients who have been resuscitated from previous arrest, patients with symptoms from abnormally fast ventricular beats (ventricular tachycardia), patients with heart failure, and patients with a recent heart attack. Doctors can treat patients at risk for cardiac arrest with drugs that help prevent abnormal heart rhythms (antiarrhythmic agents) or with electrical devices that are inserted under the skin (implantable cardioverter defibrillators [ICDs]). The ICDs detect abnormally fast heartbeats and give an electronic shock to the heart to return it to normal rhythm. Although ICDs can prevent deaths from cardiac arrest, it is unclear which types of patients are most likely to benefit from them.
Why did the researchers do this particular study?
To see which types of patients benefit from ICDs.
Who was studied?
4909 patients with heart disease who had participated in eight different studies.
How was the study done?
Rather than doing a new study, the researchers analyzed information from eight randomized trials that had assessed long-term effects of ICDs. All of the patients in the trials had some problem with their hearts. They were randomly assigned to receive an ICD or "usual care." Usual care often included antiarrhythmic drug therapy. Patients in the trials were followed for about 2 to 5 years. The authors grouped and combined the results from all of the trials in a special way (meta-analysis) to see whether ICDs reduced deaths more often than usual care in particular types of patients.
What did the researchers find?
The researchers found that, compared with usual care, ICDs more often prevented death in certain types of patients. These included patients with previous cardiac arrest, patients with symptoms from abnormally fast beats of the ventricles, and some patients with decreased heart muscle strength (left ventricular dysfunction) from coronary artery disease or heart attack. Patients with left ventricular dysfunction who benefited from ICDs often had fast heartbeats of the ventricles (asymptomatic nonsustained ventricular tachycardia) and abnormal heartbeats (sustained ventricular tachycardia) when special tests of the heart's electrical conducting system (electrophysiologic studies) were done.
What were the limitations of the study?
The study did not address costs, and ICDs are very expensive. The study included only eight trials; however, this is all the information that is currently available. More trials with additional patients are needed to figure out more precisely which patients with heart attacks and which patients with left ventricular dysfunction benefit from ICDs.
What are the implications of the study?
Implantable cardioverter defibrillators prevent death from cardiac arrest in many types of patients with heart disease.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
 |
|
 S. K H Lam and A. Owen Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials BMJ, November 3, 2007; 335(7626): 925 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Curtis, S. M. Al-Khatib, A. M. Shea, B. G. Hammill, A. F. Hernandez, and K. A. Schulman Sex Differences in the Use of Implantable Cardioverter-Defibrillators for Primary and Secondary Prevention of Sudden Cardiac Death JAMA, October 3, 2007; 298(13): 1517 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction Ann Intern Med, August 21, 2007; 147(4): 251 - 262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole, G. Raciti, M. G. Bongiorni, G. De Martino, S. Favale, M. Gasparini, R. Luise, E. Occhetta, and A. Proclemer Defibrillation testing at the time of implantation of cardioverter defibrillator in the clinical practice: a nation-wide survey Europace, July 1, 2007; 9(7): 540 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Bailey, M. Hodges, and T. R. Church Decision to Implant a Cardioverter Defibrillator after Myocardial Infarction: The Role of Ejection Fraction v. Other Risk Factor Markers Med Decis Making, March 1, 2007; 27(2): 151 - 160. [Abstract] [PDF]
|
|
|
|
 |
|
 M. A. Hlatky and D. B. Mark The high cost of implantable defibrillators Eur. Heart J., February 2, 2007; 28(4): 388 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108. [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
|
|
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
|
|
C. Ypenburg, L. van Erven, G. B. Bleeker, J. J. Bax, M. Bootsma, M. C. Wijffels, E. E. van der Wall, and M. J. Schalij Benefit of Combined Resynchronization and Defibrillator Therapy in Heart Failure Patients With and Without Ventricular Arrhythmias J. Am. Coll. Cardiol., August 1, 2006; 48(3): 464 - 470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Chan, K. Stein, T. Chow, M. Fendrick, J. T. Bigger, and S. Vijan Cost-Effectiveness of a Microvolt T-Wave Alternans Screening Strategy for Implantable Cardioverter-Defibrillator Placement in the MADIT-II-Eligible Population J. Am. Coll. Cardiol., July 4, 2006; 48(1): 112 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Lindner, J. Sorensen, J. Vogt, E. Fricke, D. Baller, D. Horstkotte, and W. Burchert Cardiac Efficiency and Oxygen Consumption Measured with 11C-Acetate PET After Long-Term Cardiac Resynchronization Therapy J. Nucl. Med., March 1, 2006; 47(3): 378 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Singh, W. J. Hall, S. McNitt, H. Wang, J. P. Daubert, W. Zareba, J. N. Ruskin, A. J. Moss, and and the MADIT-II Investigators Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation: Findings From the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1712 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, D. C. Kambouraki, D. A. Arfanakis, and P. E. Vardas Amino-Terminal Pro-Brain Natriuretic Peptide Predicts Ventricular Arrhythmogenesis in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillators Chest, October 1, 2005; 128(4): 2604 - 2610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Chan and R. A. Hayward Mortality Reduction by Implantable Cardioverter-Defibrillators in High-Risk Patients With Heart Failure, Ischemic Heart Disease, and New-Onset Ventricular Arrhythmia: An Effectiveness Study J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1474 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Pauker, N. A. M. Estes, and D. N. Salem Preventing Sudden Cardiac Death: Can We Afford the Benefit? Ann Intern Med, April 19, 2005; 142(8): 664 - 666. [Full Text] [PDF]
|
|
|
|
|
|
T. H. Makikallio, P. Barthel, R. Schneider, A. Bauer, J. M. Tapanainen, M. P. Tulppo, G. Schmidt, and H. V. Huikuri Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era Eur. Heart J., April 2, 2005; 26(8): 762 - 769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Parkes, D. L Chase, A. Grace, D. Cunningham, and P. J Roderick Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis BMJ, February 26, 2005; 330(7489): 454 - 455. [Full Text] [PDF]
|
|
|
|
|
|
F. A. McAlister, N. Wiebe, and W. Abraham Cardiac Resynchronization Therapy in Heart Failure Ann Intern Med, February 15, 2005; 142(4): 307 - 308. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hlatky, G. D. Sanders, and D. K. Owens Evidence-Based Medicine And Policy: The Case Of The Implantable Cardioverter Defibrillator Health Aff., January 1, 2005; 24(1): 42 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nanthakumar, A. E. Epstein, G. N. Kay, V. J. Plumb, and D. S. Lee Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: A pooled analysis of 10 primary prevention trials J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2166 - 2172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Kaufman, J. K. Shim, and A. J. Russ Revisiting the Biomedicalization of Aging: Clinical Trends and Ethical Challenges Gerontologist, December 1, 2004; 44(6): 731 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Parkash, A. Tang, G. Wells, J. Blackburn, I. Stiell, C. Simpson, P. Dorian, R. Yee, D. Cameron, S. Connolly, et al. Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study Can. Med. Assoc. J., October 26, 2004; 171(9): 1053 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M T Kearney, K A A Fox, A J Lee, W P Brooksby, A M Shah, A Flapan, R J Prescott, R Andrews, P D Batin, D L Eckberg, et al. Predicting sudden death in patients with mild to moderate chronic heart failure Heart, October 1, 2004; 90(10): 1137 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nichol, P. Kaul, E. Huszti, and J. F.P. Bridges Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure Ann Intern Med, September 7, 2004; 141(5): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. McAlister, J. A. Ezekowitz, N. Wiebe, B. Rowe, C. Spooner, E. Crumley, L. Hartling, T. Klassen, and W. Abraham Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med, September 7, 2004; 141(5): 381 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Pirk, J. Bytesnik, J. Kautzner, P. Peichl, V. Vancura, K. Lefflerova, I. Skalsky, and V. Vinduska Surgical ablation of post-infarction ventricular tachycardia guided by mapping in sinus rhythm: long term results Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. B. Fye Introduction: the origins and implications of a growing shortage of cardiologists J. Am. Coll. Cardiol., July 21, 2004; 44(2): 221 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Z. Pantilat and A. E. Steimle Palliative Care for Patients With Heart Failure JAMA, May 26, 2004; 291(20): 2476 - 2482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Hlatky Evidence-Based Use of Cardiac Procedures and Devices N. Engl. J. Med., May 20, 2004; 350(21): 2126 - 2128. [Full Text] [PDF]
|
|
|
|
|
|
A. Roguin, C. S. Bomma, K. Nasir, H. Tandri, C. Tichnell, C. James, J. Rutberg, J. Crosson, P. J. Spevak, R. D. Berger, et al. Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1843 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Cohn Defibrillators and Sudden Death Ann Intern Med, December 16, 2003; 139(12): W-84 - W-84. [Full Text] [PDF]
|
|
|
|
|
|
M. R. Reynolds and M. E. Josephson MADIT II (Second Multicenter Automated Defibrillator Implantation Trial) Debate: Risk Stratification, Costs, and Public Policy Circulation, October 14, 2003; 108(15): 1779 - 1783. [Full Text] [PDF]
|
|
|
|
 |
|
 ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., September 1, 2003; 8(5): 131 - 131. [Full Text] [PDF]
|
|
|
|
|
|
I. Malik JournalScan Heart, August 1, 2003; 89(8): 959 - 960. [Full Text] [PDF]
|
|
|
|
|
|
I. Malik JournalScan Heart, June 1, 2003; 89(6): 695 - 695. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Bradley Combining Resynchronization and Defibrillation Therapies for Heart Failure JAMA, May 28, 2003; 289(20): 2719 - 2721. [Full Text] [PDF]
|
|
|
|
 |
|
 Who Will Benefit Most from ICDs? Hint of an Answer Journal Watch Cardiology, May 16, 2003; 2003(516): 2 - 2. [Full Text]
|
|
|
|
 |
|
 Who Should Receive an ICD? Journal Watch (General), April 8, 2003; 2003(408): 5 - 5. [Full Text]
|
|
|
|
|
|
A. E. Buxton The Clinical Use of Implantable Cardioverter Defibrillators: Where Are We Now? Where Should We Go? Ann Intern Med, March 18, 2003; 138(6): 512 - 514. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article
